Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cobimetinib-induced “dropped head syndrome” and subsequent disease management in an Erdheim-Chester patient
    Journal Article

    King, A. C.; Diamond, E. L.; Orozco, J. S.; Morse, H. R.; Ouyang, L. L.; Schöder, H.; Rampal, R. K.
    Clinical Case Reports (2019)

    Fulltext@MSK | Save
  • Differentiation syndrome in acute promyelocytic leukaemia
    Review

    Stahl, M.; Tallman, M. S.
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors
    Journal Article

    Trivedi, G.; Inoue, D.; Chen, C.; Bitner, L.; Chung, Y. R.; Taylor, J.; Gönen, M.; Wess, J.; Abdel-Wahab, O.; Zhang, L.
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • Spliceosomal disruption of the non-canonical BAF complex in cancer
    Journal Article

    Inoue, D.; Chew, G. L.; Liu, B.; Michel, B. C.; Pangallo, J.; D’Avino, A. R.; Hitchman, T.; North, K.; Lee, S. C. W.; Bitner, L.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • CD97 is a critical regulator of acute myeloid leukemia stem cell function
    Journal Article

    Martin, G. H.; Roy, N.; Chakraborty, S.; Desrichard, A.; Chung, S. S.; Woolthuis, C. M.; Hu, W.; Berezniuk, I.; Garrett-Bakelman, F. E.; Hamann, J.; more...
    Journal of Experimental Medicine (2019)

    Fulltext@MSK | Save
  • Activation of JAK/STAT signaling in megakaryocytes sustains myeloproliferation in vivo
    Journal Article

    Woods, B.; Chen, W.; Chiu, S.; Marinaccio, C.; Fu, C.; Gu, L.; Bulic, M.; Yang, Q.; Zouak, A.; Jia, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in IDH1-mutant relapsed or refractory myelodysplastic syndrome: Updated results from a phase 1 study
    Meeting Abstract

    DiNardo, C. D.; Foran, J. M.; Watts, J. M.; Stein, E. M.; de Botton, S.; Fathi, A. T.; Prince, G. T.; Stein, A. S.; Stone, R. M.; Patel, P. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Combination of asciminib+nilotinib or asciminib+dasatinib in previously treated chronic myeloid leukemia (CML) patients: Phase 1 study results
    Meeting Abstract

    DeAngelo, D. J.; Mauro, M. J.; Kim, D. W.; Cortes, J.; Réa, D.; Hughes, T. P.; Minami, H.; Breccia, M.; Talpaz, M.; Hochhaus, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • DASFREE: Treatment-free remission (TFR) after discontinuation of dasatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR)
    Meeting Abstract

    Shah, N. P.; Garcia-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Luciano, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A multicenter, randomized phase 3 study of asciminib (ABL001) vs bosutinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 TKIs
    Meeting Abstract

    Mauro, M. J.; Hochhaus, A.; Boquimpani, C.; Minami, Y.; Allepuz, A.; Polydoros, F.; Bédoucha, V.; Aimone, P.; Réa, D.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save